BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18756441)

  • 1. PKC-mediated secretion of death factors in LNCaP prostate cancer cells is regulated by androgens.
    Xiao L; Gonzalez-Guerrico A; Kazanietz MG
    Mol Carcinog; 2009 Mar; 48(3):187-195. PubMed ID: 18756441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phorbol ester-induced apoptosis in prostate cancer cells via autocrine activation of the extrinsic apoptotic cascade: a key role for protein kinase C delta.
    Gonzalez-Guerrico AM; Kazanietz MG
    J Biol Chem; 2005 Nov; 280(47):38982-91. PubMed ID: 16183650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgens regulate protein kinase Cdelta transcription and modulate its apoptotic function in prostate cancer cells.
    Gavrielides MV; Gonzalez-Guerrico AM; Riobo NA; Kazanietz MG
    Cancer Res; 2006 Dec; 66(24):11792-801. PubMed ID: 17178875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Signaling Network Controlling Androgenic Repression of c-Fos Protein in Prostate Adenocarcinoma Cells.
    Shankar E; Song K; Corum SL; Bane KL; Wang H; Kao HY; Danielpour D
    J Biol Chem; 2016 Mar; 291(11):5512-5526. PubMed ID: 26786102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway.
    Tanaka Y; Gavrielides MV; Mitsuuchi Y; Fujii T; Kazanietz MG
    J Biol Chem; 2003 Sep; 278(36):33753-62. PubMed ID: 12824193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PMA induces androgen receptor downregulation and cellular apoptosis in prostate cancer cells.
    Itsumi M; Shiota M; Yokomizo A; Takeuchi A; Kashiwagi E; Dejima T; Inokuchi J; Tatsugami K; Uchiumi T; Naito S
    J Mol Endocrinol; 2014 Aug; 53(1):31-41. PubMed ID: 24780839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of prostate cancer cell survival by protein kinase Cepsilon involves bad phosphorylation and modulation of the TNFalpha/JNK pathway.
    Meshki J; Caino MC; von Burstin VA; Griner E; Kazanietz MG
    J Biol Chem; 2010 Aug; 285(34):26033-40. PubMed ID: 20566643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A protein kinase C/protein kinase D pathway protects LNCaP prostate cancer cells from phorbol ester-induced apoptosis by promoting ERK1/2 and NF-{kappa}B activities.
    Chen J; Giridhar KV; Zhang L; Xu S; Wang QJ
    Carcinogenesis; 2011 Aug; 32(8):1198-206. PubMed ID: 21665893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bryostatin 1 inhibits phorbol ester-induced apoptosis in prostate cancer cells by differentially modulating protein kinase C (PKC) delta translocation and preventing PKCdelta-mediated release of tumor necrosis factor-alpha.
    von Burstin VA; Xiao L; Kazanietz MG
    Mol Pharmacol; 2010 Sep; 78(3):325-32. PubMed ID: 20516369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line.
    Mizokami A; Gotoh A; Yamada H; Keller ET; Matsumoto T
    J Urol; 2000 Sep; 164(3 Pt 1):800-5. PubMed ID: 10953159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ROCK mediates phorbol ester-induced apoptosis in prostate cancer cells via p21Cip1 up-regulation and JNK.
    Xiao L; Eto M; Kazanietz MG
    J Biol Chem; 2009 Oct; 284(43):29365-75. PubMed ID: 19667069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer.
    Arnoldussen YJ; Lorenzo PI; Pretorius ME; Waehre H; Risberg B; Maelandsmo GM; Danielsen HE; Saatcioglu F
    Cancer Res; 2008 Nov; 68(22):9255-64. PubMed ID: 19010898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
    Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C
    Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of FLIP expression by androgens protects prostate cancer cells from TRAIL-mediated apoptosis.
    Raclaw KA; Heemers HV; Kidd EM; Dehm SM; Tindall DJ
    Prostate; 2008 Nov; 68(15):1696-706. PubMed ID: 18726983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of apoptosis in prostate cancer cells by androgens is mediated through downregulation of c-Jun N-terminal kinase activation.
    Lorenzo PI; Saatcioglu F
    Neoplasia; 2008 May; 10(5):418-28. PubMed ID: 18472959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phorbol ester-induced apoptosis of C4-2 cells requires both a unique and a redundant protein kinase C signaling pathway.
    Yin L; Bennani-Baiti N; Powell CT
    J Biol Chem; 2005 Feb; 280(7):5533-41. PubMed ID: 15611126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JNK interacting protein 1 (JIP-1) protects LNCaP prostate cancer cells from growth arrest and apoptosis mediated by 12-0-tetradecanoylphorbol-13-acetate (TPA).
    Ikezoe T; Yang Y; Taguchi H; Koeffler HP
    Br J Cancer; 2004 May; 90(10):2017-24. PubMed ID: 15138488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of protein kinase C-induced apoptosis in prostate cancer cells.
    Gonzalez-Guerrico AM; Meshki J; Xiao L; Benavides F; Conti CJ; Kazanietz MG
    J Biochem Mol Biol; 2005 Nov; 38(6):639-45. PubMed ID: 16336777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase.
    Singh SV; Choi S; Zeng Y; Hahm ER; Xiao D
    Cancer Res; 2007 Aug; 67(15):7439-49. PubMed ID: 17671214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation-mediated abrogation of androgen signaling: an in vitro model of prostate cell inflammation.
    Debelec-Butuner B; Alapinar C; Varisli L; Erbaykent-Tepedelen B; Hamid SM; Gonen-Korkmaz C; Korkmaz KS
    Mol Carcinog; 2014 Feb; 53(2):85-97. PubMed ID: 22911881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.